World News: 13:00 GMT Friday 9th November 2018. [CytomX Therapeutics Inc. via Globe Newswire via SPi World News]
SOUTH SAN FRANCISCO Calif Nov 09 2018 GLOBE NEWSWIRE -- CytomX Therapeutics Inc Nasdaq CTMX a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody...
Globe Newswire: 13:00 GMT Friday 9th November 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.